Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

Not Applicable

Completed

• Conditions: Analgesia
• Interventions: Procedure: Bilevel erector spinae plane block; Drug: Intravenous morphine; Procedure: Single level erector spinae plane block

• Registration Number: NCT05429489
• Lead Sponsor: National Cancer Institute, Egypt

Brief Summary

This study aims at comparing the analgesic efficacy and safety of bilevel erector spinae versus single level versus general anesthesia for breast cancer surgeries

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-06-17
• Study First Submitted QC: 2022-06-17
• Study First Posted: 2022-06-23
• Study Start: 2022-06-27
• Primary Completion: 2023-12-27
• Status Verified: 2024-01
• Study Completion: 2024-01-10
• Last Update Submitted: 2024-01-20
• Last Update Posted: 2024-01-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 126

Inclusion Criteria

• Female
• Diagnosed with breast cancer

Exclusion Criteria

• Patient refusal
• coagulation defects
• bone metastases
• abnormal kidney and/or liver function tests

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Bilevel erector spinae plane block	Bilevel erector spinae plane block	Bilevel erector spinae block at 3rd and 5th thoracic vertebral levels
Intravenous morphine	Intravenous morphine	Intravenous morphine 0.1 mg/ kg
Single level erector spinae plane block	Single level erector spinae plane block	single level erector spinae plane block at 5th thoracic vertebral levels

Primary Outcome Measures

Name	Time	Method
Total analgesic requisite	First 24 hours postoperatively	total postoperative morphine consumption

Trial Locations

Locations (1)

Walaa Y Elsabeeny; 🇪🇬 Cairo, Egypt